@WSJ @JohnCarreyrou Why is this company covered at least 2x a week on WSJ, just curious why you consider them relevant?
-
-
-
@kevinpnolan@WSJ@JohnCarreyrou they are relevant because they threaten the high margins of the big players.#Theranos -
@athanasios9@WSJ@JohnCarreyrou but when the science and data behind the company cannot be validated, they've lost cred and time's up. -
@kevinpnolan@WSJ@JohnCarreyrou as long as all govt concerns are addressed, they have until their $'s run out. No denying smear campaign
End of conversation
New conversation -
-
-
@WSJ Capital BlueCross made a the right action. No more experiment with the human being, please!Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
“
@WSJ: Theranos stops drawing blood from patients at Capital BlueCross Pennsylvania store http://on.wsj.com/1m1RKyd ” What is#WALGREENS doing?Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
@WSJ#Putin - Russian pride!#Russiapic.twitter.com/lpGWz1HSDtThis media may contain sensitive material. Learn more
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.